These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13378604)

  • 1. Studies in regional heparinization. I. The use of simultaneous neutralization with protamine; preliminary studies.
    GORDON LA; PERKINS HA; RICHARDS V
    N Engl J Med; 1956 Nov; 255(22):1025-9. PubMed ID: 13378604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin-protamine-protocol].
    Nomoto S
    Nihon Geka Hokan; 1997 May; 66(2):49-50. PubMed ID: 9796248
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of blood flow and the effect of protamine on the thromboresistant properties of a covalently bonded heparin surface.
    Arnander C; Olsson P; Larm O
    J Biomed Mater Res; 1988 Oct; 22(10):859-68. PubMed ID: 3220839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discussion of the report of Marx and Borst. I. The heparinization of patients and the neutralization of heparin with protamine sulfate].
    LOELIGER EA
    Thoraxchirurgie; 1961 Jun; 9():84-90. PubMed ID: 13763096
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies in regional heparinization. II. Artificial-kidney hemodialysis without systemic heparinization; preliminary report of a method using simultaneous infusion of heparin and protamine.
    GORDON LA; PERKINS HA; RICHARDS V; RUKES JM; SIMON ER
    N Engl J Med; 1956 Dec; 255(23):1063-6. PubMed ID: 13378613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental research on prolonged regional heparinization by continuous perfusion of combined heparin and protamine sulfate].
    PERRELLI L; REVIGNAS A
    Rass Med Sarda; 1960; 62():357-72. PubMed ID: 13734507
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralization of heparin activity.
    Pai M; Crowther MA
    Handb Exp Pharmacol; 2012; (207):265-77. PubMed ID: 22566228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can protamine be used during perfusion with heparin surface coated equipment?
    von Segesser LK; Gyurech DD; Schilling JJ; Marquardt K; Turina MI
    ASAIO J; 1993; 39(3):M190-4. PubMed ID: 8268526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional heparinization in perfusion of the kidney in situ.
    Carswell F; Hainsworth R; Ledsome JR
    J Physiol; 1967 Jul; 191(2):63P-65P. PubMed ID: 6050123
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in a short-term pig model.
    Dickey LA; Butler TJ; Bergmann TM; Bates ME; Null DM
    Perfusion; 1994; 9(5):327-33. PubMed ID: 7833540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
    Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
    Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the adequacy of heparin administration during hemosorption].
    Iunovidova LI; Lekhtman AM; Levantovskaia OM
    Khirurgiia (Mosk); 1990 Jun; (6):85-8. PubMed ID: 2214584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
    von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
    Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin.
    Samoszuk M; Corwin M; Yu H; Wang J; Nalcioglu O; Su MY
    Thromb Haemost; 2003 Aug; 90(2):351-60. PubMed ID: 12888884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity.
    Wakefield TW; Whitehouse WM; Stanley JC
    J Vasc Surg; 1984 Mar; 1(2):346-55. PubMed ID: 6481883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing heparin neutralization following cardiac surgery: sensitivity of thrombin time-based assays versus protamine titration methods.
    LaDuca FM; Zucker ML; Walker CE
    Perfusion; 1999 May; 14(3):181-7. PubMed ID: 10411247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible effects of anticoagulants and protamine on alimentary lipaemia.
    BROWN WD
    Q J Exp Physiol Cogn Med Sci; 1952; 37(2):75-84. PubMed ID: 14949318
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.
    Kuziej J; Litinas E; Hoppensteadt DA; Liu D; Walenga JM; Fareed J; Jeske W
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):377-86. PubMed ID: 20460347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.